SCHEMBL30440766

SCHEMBL30440766

CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ FNTA P49354 15/20 0.47
▸ FNTB P49356 15/20 0.47
▸ PGGT1B P53609 13/20 0.47
▸ NPY4R P50391 4/20 0.41
▸ NPY1R P25929 3/20 0.41
▸ NPY2R P49146 2/20 0.41
▸ NPY5R Q15761 2/20 0.41
▸ FOLH1 Q04609 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31157766 1.00 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL31157769 1.00 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL30173918 1.00 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL30173822 0.98 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL30173879 0.98 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL30173868 0.98 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL30173871 0.98 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL30463241 0.98 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL30173943 0.98 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL30173818 0.98 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747264-A1 MICELLAR BIOACTIVE COLLAGEN-STIMULATING LIPOPEPTIDE University of Reading (GB) 2026-05-27 — — EP disclosed
CN-120209084-A Cyclohexapeptides, compositions and uses thereof 深圳市维琪科技股份有限公司 2025-06-27 — — CN disclosed
EP-4568754-A1 PERSONAL CARE COMPOSITIONS Colgate-Palmolive Company (US) 2025-06-18 — — EP disclosed
US-20250082567-A1 FACIAL COSMETIC COMPOSITIONS AND METHODS OF IMPROVING FACIAL AESTHETICS Aforé LLC 2025-03-13 — — US disclosed
WO-2025037123-A1 MICELLAR BIOACTIVE COLLAGEN-STIMULATING LIPOPEPTIDE UNIVERSITY OF READING (GB) 2025-02-20 — — WO disclosed
CN-119143848-A Cyclic heptapeptide-4 and preparation method and application thereof 杭州湃肽生化科技有限公司 2024-12-17 — — CN disclosed
CN-119080885-A Cyclic nonapeptide-1 and preparation method and application thereof 杭州湃肽生化科技有限公司 2024-12-06 — — CN disclosed
CN-119039399-A Cyclic octapeptide-3 and preparation method and application thereof 杭州湃肽生化科技有限公司 2024-11-29 — — CN disclosed
CN-119039398-A Functional cyclic peptide and preparation method and application thereof 杭州湃肽生化科技有限公司 2024-11-29 — — CN disclosed
CN-119019504-A Cyclopentapeptide-4, and preparation method and application thereof 杭州湃肽生化科技有限公司 2024-11-26 — — CN disclosed
EP-3548510-B1 COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES LUBRIZOL ADVANCED MAT INC (US) 2024-10-02 — — EP disclosed
CN-117462440-B Functional cyclic peptide and preparation method and application thereof 杭州湃肽生化科技有限公司 2024-09-13 — — CN disclosed
US-20240050360-A1 Personal Care Compositions COLGATE-PALMOLIVE COMPANY (US) 2024-02-15 — — US disclosed
WO-2024035908-A1 PERSONAL CARE COMPOSITIONS COLGATE-PALMOLIVE COMPANY (US) 2024-02-15 — — WO disclosed
CN-117462440-A Functional cyclic peptide and preparation method and application thereof 杭州湃肽生化科技有限公司 2024-01-30 — — CN disclosed
US-20230415070-A1 EUTECTIC COMPOSITIONS, METHODS AND USES THEREOF UNIVERSIDADE DO MINHO (PT) 2023-12-28 — — US disclosed
CN-111278420-B Active substance-hexapeptide complex and cosmetic composition comprising same 安尼根有限公司 2023-09-19 — — CN disclosed
CN-116583338-A Eutectic composition, method and use thereof 米尼翁大学 2023-08-11 — — CN disclosed
US-20230233446-A1 FACIAL COSMETIC COMPOSITIONS AND METHODS OF IMPROVING FACIAL AESTHETICS Aforé LLC 2023-07-27 — — US disclosed
CN-116223583-A Single-molecule detection method of anti-aging oligopeptide based on solid-state nanopore technology 中国科学院重庆绿色智能技术研究院 2023-06-06 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230233446-A1 FACIAL COSMETIC COMPOSITIONS AND METHODS OF IMPROVING FACIAL AESTHETICS RXRG, RXRA, RXRB FNTA 1749/4885FNTB 1855/4885PGGT1B 1137/4885
US-20230415070-A1 EUTECTIC COMPOSITIONS, METHODS AND USES THEREOF DGAT2, DLAT, DGKB FNTA 933/4885FNTB 1318/4885PGGT1B 545/4885
US-20250082567-A1 FACIAL COSMETIC COMPOSITIONS AND METHODS OF IMPROVING FACIAL AESTHETICS RXRG, RXRA, RXRB FNTA 1749/4885FNTB 1855/4885PGGT1B 1137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback